Avicanna Inc. is a biopharmaceutical company based in Toronto, Canada, specializing in the research, development, and commercialization of plant-derived cannabinoid-based products for the medical, consumer health, and pharmaceutical sectors. The company offers a range of pharmaceutical-grade cannabinoids, including THC, CBD, and CBG, along with active pharmaceutical ingredients, feminized seeds, and bulk formulations, primarily under the Aureus Santa Marta brand. Avicanna also develops CBD-based derma-cosmetic products for beauty and specialized care under the Pura Earth brand and provides medical cannabis products targeting various health issues, including skin disorders and neurological conditions. Furthermore, the company engages in research collaborations to explore cannabinoid applications, such as developing treatments for COVID-19 induced lung inflammation. Founded in 2016, Avicanna emphasizes an evidence-based approach and maintains vertical integration within the biotechnology and medical cannabis industries.